Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kulis

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|January 13, 2012
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapyMichael Kulis, Katie Saba, Edwin H Kim, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Allergy and Clinical Immunology|July 16, 2017
Specific allergen profiles of peanut foods and diagnostic or therapeutic allergenic productsStephanie Filep, Denise S Block, Bryan R E Smith, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitizationEdwin H Kim, J Andrew Bird, Michael Kulis, et al.
Allergy|October 21, 2025
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old ChildrenNeel Singh, Janelle Kesselring, Jess Humphrey, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 21, 2018
High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young childrenMichael Kulis, Xiaohong Yue, Rishu Guo, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2017
Effect of endotoxin and alum adjuvant vaccine on peanut allergyBrandi T Johnson-Weaver, Susan McRitchie, Kelly A Mercier, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2012
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergensBrian P Vickery, Jing Lin, Michael Kulis, et al.
Clinical and Translational Gastroenterology|December 3, 2019
A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic EsophagitisEvan S Dellon, Rishu Guo, Sarah J McGee, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|January 13, 2012
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapyMichael Kulis, Katie Saba, Edwin H Kim, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 31, 2017
Preparation and Analysis of Peanut Flour Used in Oral Immunotherapy Clinical TrialsJelena P Berglund, Nicole Szczepanski, Anusha Penumarti, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2015
Modified peanut oral immunotherapy protocol safely and effectively induces desensitizationJ Andrew Bird, Matthew Feldman, Amy Arneson, et al.
The Journal of Allergy and Clinical Immunology|July 16, 2017
Specific allergen profiles of peanut foods and diagnostic or therapeutic allergenic productsStephanie Filep, Denise S Block, Bryan R E Smith, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2011
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitizationEdwin H Kim, J Andrew Bird, Michael Kulis, et al.
Allergy|October 21, 2025
Peanut Component-Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1-4-Year-Old ChildrenNeel Singh, Janelle Kesselring, Jess Humphrey, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|August 21, 2018
High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young childrenMichael Kulis, Xiaohong Yue, Rishu Guo, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2017
Effect of endotoxin and alum adjuvant vaccine on peanut allergyBrandi T Johnson-Weaver, Susan McRitchie, Kelly A Mercier, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2012
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergensBrian P Vickery, Jing Lin, Michael Kulis, et al.
Clinical and Translational Gastroenterology|December 3, 2019
A Novel Allergen-Specific Immune Signature-Directed Approach to Dietary Elimination in Eosinophilic EsophagitisEvan S Dellon, Rishu Guo, Sarah J McGee, et al.
Pageof 3